CPRX vs. FLGT
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Fulgent Genetics, Inc. (FLGT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPRX or FLGT.
Key characteristics
| CPRX | FLGT | |
|---|---|---|
| YTD Return | 37.06% | -33.73% |
| 1Y Return | 82.42% | -26.98% |
| 3Y Return (Ann) | 46.18% | -40.15% |
| 5Y Return (Ann) | 37.57% | 11.55% |
| Sharpe Ratio | 1.85 | -0.70 |
| Sortino Ratio | 2.53 | -0.83 |
| Omega Ratio | 1.32 | 0.90 |
| Calmar Ratio | 1.98 | -0.30 |
| Martin Ratio | 8.45 | -1.06 |
| Ulcer Index | 9.39% | 25.39% |
| Daily Std Dev | 42.77% | 38.54% |
| Max Drawdown | -94.25% | -89.62% |
| Current Drawdown | -3.72% | -89.58% |
Fundamentals
| CPRX | FLGT | |
|---|---|---|
| Market Cap | $2.75B | $586.04M |
| EPS | $1.18 | -$5.52 |
| PEG Ratio | 0.00 | 1.32 |
| Total Revenue (TTM) | $458.21M | $277.76M |
| Gross Profit (TTM) | $376.80M | $94.66M |
| EBITDA (TTM) | $202.05M | -$69.32M |
Correlation
The correlation between CPRX and FLGT is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CPRX vs. FLGT - Performance Comparison
In the year-to-date period, CPRX achieves a 37.06% return, which is significantly higher than FLGT's -33.73% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPRX vs. FLGT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Fulgent Genetics, Inc. (FLGT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CPRX vs. FLGT - Dividend Comparison
Neither CPRX nor FLGT has paid dividends to shareholders.
Drawdowns
CPRX vs. FLGT - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than FLGT's maximum drawdown of -89.62%. Use the drawdown chart below to compare losses from any high point for CPRX and FLGT. For additional features, visit the drawdowns tool.
Volatility
CPRX vs. FLGT - Volatility Comparison
The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 7.76%, while Fulgent Genetics, Inc. (FLGT) has a volatility of 16.73%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than FLGT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CPRX vs. FLGT - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Fulgent Genetics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities